Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by thed1983on Mar 04, 2021 12:30pm
213 Views
Post# 32715818

Not Bashing - Just read the info available online.

Not Bashing - Just read the info available online.I urge any new investors who got sucked into to big % moves last Friday and Monday to take an hour or so and read REAL infomation about the company.

https://www.sedar.com/DisplayCompanyDocuments.do?lang=EN&issuerNo=00021766

Start with the MD&A on Nov 27, 2020 - and work forward from there.

- No CASH on hand (or whatever is left from the $300k they raised @ 0.015 cents)
- No sales, license fees, or roylaties to fund the business in the short term.
- Debt.
- MILLIONS in guarentees, and future stock issuance to "partners" or former debt holders if they are able to pull off a miracle, and actually generate an approval or revenue.

This is the venture exchange - a "grown up" version of gambling. If your thinking about buying now your probably too late. If you bought in - and are now bag holding - dump and preserve whatever capital you have left.

I held the bag on this for a long time - and thanks to a heroic pump last Friday - managed to get out with a couple of extra bucks in my pocket. But that was just dumb luck.

My two cents - DYODD and good luck (because if you own KLY shares - luck is what you will need).




<< Previous
Bullboard Posts
Next >>